Improving Recombinant Zoster Vaccination Rates in Patients Receiving Biologic Therapy in the Rheumatology Clinics at the Orlando VA Healthcare System

Authors

Kathlyn Camargo Macias, HCA HealthcareFollow
Taylor Kann, HCA HealthcareFollow
Marilyn Mosquera, HCA HealthcareFollow
Ravi Shahu Khal, HCA HealthcareFollow
Ashwini Komarla, HCA HealthcareFollow

Files

Division

North Florida

Hospital

Osceola Regional Medical Center

Specialty

Internal Medicine

Document Type

Presentation

Publication Date

2022

Keywords

herpes zoster vaccine, quality improvement

Disciplines

Internal Medicine | Quality Improvement

Abstract

No abstract available.

Original Publisher

UCF/VA QI & Patient Safety Forum

Recommended Citation

Camargo Macias, Kathlyn; Kann, Taylor; Mosquera, Marilyn; Shahu Khal, Ravi; and Komarla, Ashwini, "Improving Recombinant Zoster Vaccination Rates in Patients Receiving Biologic Therapy in the Rheumatology Clinics at the Orlando VA Healthcare System" (2022). North Florida Division Research Day 2022. 12.
https://scholarlycommons.hcahealthcare.com/northflorida2022/12